Abstract
Radical cystectomy and urinary diversion are the current gold standard of management for patients with muscle-invasive bladder cancer. While it is a common urologic procedure, it is associated with significant patient morbidity and mortality. Complications associated with the operation are often frequent, although minor, and significantly impact functional outcomes as well as patient quality of life. Frailty is emerging as a new preoperative prognostic indicator to help determine which patients are at greatest risk of poor outcomes and postoperative complications after treatment. In this review, we summarize the current known literature analyzing frailty as a significant prognostic risk factor of short-term and long-term outcomes after radical cystectomy and urinary diversion in the treatment of muscle-invasive bladder cancer.
Similar content being viewed by others
References
PDQ Cancer Information Summaries (2019) Bladder cancer treatment. National Cancer Institute, USA
Krishna SR, Konety BR (2017) Current concepts in the management of muscle invasive bladder cancer. Indian J Surg Oncol 8(1):74–81. https://doi.org/10.1007/s13193-016-0586-1
Nguyen TT, Huillard O, Dabi Y, Anract J, Sibony M, Zerbib M, Xylinas E (2018) Neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and its impact on surgical morbidity and oncological outcomes: a real-world experience. Front Surg 5:58. https://doi.org/10.3389/fsurg.2018.00058
Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, Raj G, Bochner BH, Dalbagni G, Herr HW, Donat SM (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55(1):164–174. https://doi.org/10.1016/j.eururo.2008.07.031
Liedberg F (2010) Early complications and morbidity of radical cystectomy. Eur Urol Suppl 9(1):25–30
Djaladat H, Katebian B, Bazargani ST, Miranda G, Cai J, Schuckman AK, Daneshmand S (2017) 90-day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study. World J Urol 35(6):907–911. https://doi.org/10.1007/s00345-016-1950-z
LeBrasseur NK, Tchkonia T, Kirkland JL (2015) Cellular senescence and the biology of aging, disease, and frailty. Nestle Nutr Inst Workshop Ser 83:11–18. https://doi.org/10.1159/000382054
Chen X, Mao G, Leng SX (2014) Frailty syndrome: an overview. Clin Interv Aging 9:433–441. https://doi.org/10.2147/cia.s45300
Fedarko NS (2011) The biology of aging and frailty. Clin Geriatr Med 27(1):27–37. https://doi.org/10.1016/j.cger.2010.08.006
Zhang X, Meng X, Chen Y, Leng SX, Zhang H (2017) The biology of aging and cancer: frailty, inflammation, and immunity. Cancer J 23(4):201–205. https://doi.org/10.1097/ppo.0000000000000270
Santilli V, Bernetti A, Mangone M, Paoloni M (2014) Clinical definition of sarcopenia. Clin Cases Miner Bone Metab 11(3):177–180
Mayr R, Fritsche HM, Zeman F, Reiffen M, Siebertz L, Niessen C, Pycha A, van Rhijn BWG, Burger M, Gierth M (2018) Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer. World J Urol 36(8):1201–1207. https://doi.org/10.1007/s00345-018-2259-x
Psutka SP, Carrasco A, Schmit GD, Moynagh MR, Boorjian SA, Frank I, Stewart SB, Thapa P, Tarrell RF, Cheville JC, Tollefson MK (2014) Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer 120(18):2910–2918. https://doi.org/10.1002/cncr.28798
Mayr R, Gierth M, Zeman F, Reiffen M, Seeger P, Wezel F, Pycha A, Comploj E, Bonatti M, Ritter M, van Rhijn BWG, Burger M, Bolenz C, Fritsche HM, Martini T (2018) Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer. J Cachexia Sarcopenia Muscle 9(3):505–513. https://doi.org/10.1002/jcsm.12279
Okita K, Hatakeyama S, Fujita N, Konishi S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Ito H, Yoshikawa K, Koie T, Ohyama C (2018) Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer. Med Oncol 36(1):7. https://doi.org/10.1007/s12032-018-1232-2
Subramaniam S, Aalberg JJ, Soriano RP, Divino CM (2018) New 5-factor modified frailty index using american college of surgeons nsqip data. J Am Coll Surg 226(2):173. https://doi.org/10.1016/j.jamcollsurg.2017.11.005
Pearl JA, Patil D, Filson CP, Arya S, Alemozaffar M, Master VA, Ogan K (2017) Patient frailty and discharge disposition following radical cystectomy. clin genitourin Cancer 15(4):e615–e621. https://doi.org/10.1016/j.clgc.2016.12.013
Suskind AM, Jin C, Cooperberg MR, Finlayson E, Boscardin WJ, Sen S, Walter LC (2016) Preoperative frailty is associated with discharge to skilled or assisted living facilities after urologic procedures of varying complexity. Urology 97:25–32. https://doi.org/10.1016/j.urology.2016.03.073
Chappidi MR, Kates M, Patel HD, Tosoian JJ, Kaye DR, Sopko NA, Lascano D, Liu JJ, McKiernan J, Bivalacqua TJ (2016) Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy. Urol Oncol 34(6):256.e251–256.e256. https://doi.org/10.1016/j.urolonc.2015.12.010
Taylor BL, Xia L, Guzzo TJ, Scherr DS, Hu JC (2019) Frailty and greater health care resource utilization following major urologic oncology surgery. Eur Urol Oncol 2(1):21–27. https://doi.org/10.1016/j.euo.2018.06.005
Chang CM, Yin WY, Wei CK, Wu CC, Su YC, Yu CH, Lee CC (2016) Adjusted age-adjusted charlson comorbidity index score as a risk measure of perioperative mortality before cancer surgery. PLoS One 11(2):e0148076. https://doi.org/10.1371/journal.pone.0148076
Liu Y, Cohen ME, Hall BL, Ko CY, Bilimoria KY (2016) Evaluation and enhancement of calibration in the american college of surgeons nsqip surgical risk calculator. J Am Coll Surg 223(2):231–239. https://doi.org/10.1016/j.jamcollsurg.2016.03.040
Owens WD, Felts JA, Spitznagel EL (1978) ASA physical status classifications: a study of consistency of ratings. Anesthesiology 49(4):239–243
Binder PS, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK (2016) Adult comorbidity evaluation 27 score as a predictor of survival in endometrial cancer patients. Am J Obstet Gynecol 215(6):766.e761–766.e769. https://doi.org/10.1016/j.ajog.2016.07.035
Atallah F, Letocart P, Malavaud B, Ahmad M, Mazerolles M, Minville V (2017) Can We Predict Morbidity and Mortality of Patients Aged 75 Years and Older Undergoing Cystectomy? J Frailty. Aging 6(2):72–75. https://doi.org/10.14283/jfa.2017.5
Jeon K, Yoo H, Jeong BH, Park HY, Koh WJ, Suh GY, Guallar E (2017) Functional status and mortality prediction in community-acquired pneumonia. Respirology 22(7):1400–1406. https://doi.org/10.1111/resp.13072
Lascano D, Pak JS, Kates M, Finkelstein JB, Silva M, Hagen E, RoyChoudhury A, Bivalacqua TJ, DeCastro GJ, Benson MC, McKiernan JM (2015) Validation of a frailty index in patients undergoing curative surgery for urologic malignancy and comparison with other risk stratification tools. Urol Oncol 33(10):426.e421. https://doi.org/10.1016/j.urolonc.2015.06.002
Sathianathen NJ, Jarosek S, Lawrentschuk N, Bolton D, Konety BR (2018) A Simplified Frailty Index to Predict Outcomes After Radical Cystectomy. Eur Urol Focus. https://doi.org/10.1016/j.euf.2017.12.011
Woldu SL, Sanli O, Clinton TN, Lotan Y (2019) Validating the predictors of outcomes after radical cystectomy for bladder cancer. Cancer 125(2):223–231. https://doi.org/10.1002/cncr.31799
Meng X, Press B, Renson A, Wysock JS, Taneja SS, Huang WC, Bjurlin MA (2018) Discriminative ability of commonly used indexes to predict adverse outcomes after radical cystectomy: comparison of demographic data, american society of anesthesiologists, modified charlson comorbidity index, and modified frailty index. Clin Genitourin Cancer 16(4):e843–e850. https://doi.org/10.1016/j.clgc.2018.02.009
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, Group CHSCR (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156
Burg ML, Clifford TG, Bazargani ST, Lin-Brande M, Miranda G, Cai J, Schuckman AK, Djaladat H, Daneshmand S (2019) Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments. Urol Oncol 37(1):40–47. https://doi.org/10.1016/j.urolonc.2018.10.002
Shariat SF, Milowsky M, Droller MJ (2009) Bladder cancer in the elderly. Urol Oncol 27(6):653–667. https://doi.org/10.1016/j.urolonc.2009.07.020
Choi Y, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Bang YJ (2015) Skeletal Muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index. PLoS One 10(10):e0139749. https://doi.org/10.1371/journal.pone.0139749
Carli F, Awasthi R, Gillis C, Kassouf W (2014) Optimizing a frail elderly patient for radical cystectomy with a prehabilitation program. Can Urol Assoc J 8(11–12):E884–E887. https://doi.org/10.5489/cuaj.2025
Funding
No funding was received for this work.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Parikh, N., Sharma, P. Frailty as a prognostic indicator in the radical cystectomy population: a review. Int Urol Nephrol 51, 1281–1290 (2019). https://doi.org/10.1007/s11255-019-02189-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-019-02189-z